Literature DB >> 17519126

Antihypertensive effects of drospirenone and 17beta-estradiol in hypertensive postmenopausal women.

Kathleen H Berecek1, Thomas D Nielsen.   

Abstract

Entities:  

Year:  2007        PMID： 17519126     DOI： 10.1007/s11906-007-0037-z

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


× No keyword cloud information.
  5 in total

1.  Effects of a new hormone therapy, drospirenone and 17-beta-estradiol, in postmenopausal women with hypertension.

Authors:  William B White; Vladimir Hanes; Vijay Chauhan; Bertram Pitt
Journal:  Hypertension       Date:  2006-06-26       Impact factor: 10.190

2.  Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial.

Authors:  David F Archer; Ian H Thorneycroft; Marie Foegh; Vladimir Hanes; Michael D Glant; Pincas Bitterman; Richard L Kempson
Journal:  Menopause       Date:  2005-11-08       Impact factor: 2.953

3.  Effects of drospirenone/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women.

Authors:  Richard A Preston; William B White; Bertram Pitt; George Bakris; Paul M Norris; Vladimir Hanes
Journal:  Am J Hypertens       Date:  2005-06       Impact factor: 2.689

4.  Effect of drospirenone on serum potassium and drospirenone pharmacokinetics in women with normal or impaired renal function.

Authors:  Rolf Schürmann; Hartmut Blode; Norbert Benda; Maureen Cronin; Andreas Küfner
Journal:  J Clin Pharmacol       Date:  2006-08       Impact factor: 3.126

5.  Additive effect of drospirenone/17-beta-estradiol in hypertensive postmenopausal women receiving enalapril.

Authors:  Richard A Preston; Alberto Alonso; Darlene Panzitta; Paul Zhang; Adel H Karara
Journal:  Am J Hypertens       Date:  2002-09       Impact factor: 2.689
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.